ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy

Sun, Huiying; Zhou, Rui*; Zheng, Yannan; Wen, Zhaowei; Zhang, Dingling; Zeng, Dongqiang; Wu, Jianhua; Huang, Zhenhua; Rong, Xiaoxiang; Huang, Na; Sun, Li; Bin, Jianping; Liao, Yulin; Shi, Min; Liao, Wangjun*南方医科大学
Oncogene2021-8-26DOI: 10.1038/s41388-021-01932-0
16被引5阅读
引用收藏
分享

摘要

Homologous recombination (HR) repair is an important determinant of chemosensitivity. However, the mechanisms underlying HR regulation remain largely unknown. Cysteine-rich intestinal protein 1 (CRIP1) is a member of the LIM/double-zinc finger protein family and is overexpressed and associated with prognosis in several tumor types. However, to date, the functional role of CRIP1 in cancer biology is poorly understood. Here we found that CRIP1 downregulation causes HR repair deficiency with concomitant increase in cell sensitivity to cisplatin, epirubicin, and the poly ADP-ribose polymerase (PARP) inhibitor olaparib in gastric cancer cells. Mechanistically, upon DNA damage, CRIP1 is deubiquitinated and upregulated by activated AKT signaling. CRIP1, in turn, promotes nuclear enrichment of RAD51, which is a prerequisite step for HR commencement, by stabilizing BRCA2 to counteract FBXO5-targeted RAD51 degradation and by binding to the core domain of RAD51 (RAD51(184-257)) in coordination with BRCA2, to facilitate nuclear export signal masking interactions between BRCA2 and RAD51. Moreover, through mass spectrometry screening, we found that KPNA4 is at least one of the carriers controlling the nucleo-cytoplasmic distribution of the CRIP1-BRCA2-RAD51 complex in response to chemotherapy. Consistent with these findings, RAD51 inhibitors block the CRIP1-mediated HR process, thereby restoring chemotherapy sensitivity of gastric cancer cells with high CRIP1 expression. Analysis of patient specimens revealed an abnormally high level of CRIP1 expression in GC tissues compared to that in the adjacent normal mucosa and a significant negative association between CRIP1 expression and survival time in patient cohorts with different types of solid tumors undergoing genotoxic treatments. In conclusion, our study suggests an essential function of CRIP1 in promoting HR repair and facilitating gastric cancer cell adaptation to genotoxic therapy.

学科与关键词

关键词
ADVANCED GASTRIC-CANCERGASTROESOPHAGEAL JUNCTION CANCERDOUBLE-BLINDCOLORECTAL-CANCER1ST-LINE THERAPYINTESTINAL-TYPECAPECITABINEOVEREXPRESSIONEXPRESSIONPROTEIN-1
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Oncogene
发表日期
2021-08-26
卷期
第 40 卷, 第 34 期
页码
5342-5355
DOI
10.1038/s41388-021-01932-0
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81772580]; Natural Science Foundation of Guangdong Province of China [2020A1515110686]; President Foundation of Nanfang Hospital, Southern Medical University [2020C020]

作者

  • S

    Sun, Huiying (第一作者)

    southern med univ

  • Z

    Zhou, Rui (通讯)

    southern med univ

查看全部 15 位作者收起作者
  • Z

    Zheng, Yannan

    southern med univ

  • W

    Wen, Zhaowei

    southern med univ

  • Z

    Zhang, Dingling

    southern med univ

  • Z

    Zeng, Dongqiang

    southern med univ

  • W

    Wu, Jianhua

    southern med univ

  • H

    Huang, Zhenhua

    southern med univ

  • R

    Rong, Xiaoxiang

    southern med univ

  • H

    Huang, Na

    southern med univ

  • S

    Sun, Li

    southern med univ

  • B

    Bin, Jianping

    southern med univ

  • L

    Liao, Yulin

    southern med univ

  • S

    Shi, Min

    southern med univ

  • L

    Liao, Wangjun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417